{"id":"W4405500883","doi":"10.51731/cjht.2024.1046","title":"Venetoclax (Venclexta)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Venetoclax; Obinutuzumab; Medicine; Chronic lymphocytic leukemia; Reimbursement; Ibrutinib; Chlorambucil; Internal medicine; Intensive care medicine; Leukemia; Oncology; Chemotherapy; Health care; Political science","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000750112,0.0003541645,0.0003968878,0.001056582,0.0008027997,0.001658185,0.0007070474,0.001011863,0.1083417],"category_scores_gemma":[0.001940729,0.0001777538,0.0004199268,0.0007420216,0.0004453356,0.0006082733,0.0008186818,0.002109024,0.01948219],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002023542,"about_ca_system_score_gemma":0.00357095,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02582229,"about_ca_topic_score_gemma":0.04731385,"domain_scores_codex":[0.9993845,0.00008106462,0.00001699727,0.00009034921,0.0003026027,0.000124458],"domain_scores_gemma":[0.9990584,0.0001331615,0.00009066018,0.00007358098,0.0001793396,0.0004648324],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001295343,0.000325081,0.002006626,0.0006050052,0.00004564409,0.000590293,0.00006908576,0.000202367,0.003931073,0.00702678,0.5481995,0.4357031],"study_design_scores_gemma":[0.0006754951,0.000318706,0.003435422,0.0002976275,0.00003696608,0.001419386,0.00002625045,0.000251078,0.001359216,0.0008407674,0.9913264,0.00001257458],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.030477,0.1588138,0.006742583,0.02062006,0.004580928,0.001285721,0.02049316,0.008882782,0.7481039],"genre_scores_gemma":[0.3168591,0.08613294,0.01301642,0.01851112,0.002943654,0.000749402,0.03666454,0.001108472,0.5240144],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.1083417,"threshold_uncertainty_score":0.3624392,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03855962024480177,"score_gpt":0.3509868339000701,"score_spread":0.3124272136552683,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}